[Business Wire] - Idera Pharmaceuticals, Inc. , a biotechnology company developing Toll-like receptor targeted drug candidates for the treatment of autoimmune diseases, today announced a presentation of preclinical data will be made by its collaborator, Dr.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment